Cytomegalovirus is one of the most important infections to occur after allogeneic
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …

Human cytomegalovirus (CMV) is a betaherpesvirus in the same family as human
herpesvirus-6 and-7. CMV is a large virus including approximately 200 proteins. CMV has …

Background Cytomegalovirus (CMV) infection is a leading cause of illness and death in
patients who have undergone allogeneic hematopoietic-cell transplantation. Available …

Abstract The Practice Guidelines Committee of the American Society for Transplantation and
Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to …

Cytomegalovirus (CMV) continues to cause major complications after hematopoietic cell
transplantation (HCT). Over the past decade, most centers have adopted preemptive …

This review focuses on recent advances in the field of cytomegalovirus (CMV). The 2 main
strategies for CMV prevention are prophylaxis and preemptive therapy. Prophylaxis …

Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT)
remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases …

Background Available drugs against cytomegalovirus have adverse effects that compromise
their prophylactic use in recipients of allogeneic stem-cell transplants. We assessed the …

Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality after
hematopoietic stem cell transplantation. Significant progress has been made in the …

Cytomegalovirus (CMV) infection is a significant complication in hematopoietic cell
transplantation (HCT) recipients. Four antiviral drugs are used for preventing or treating …